Results 1 to 10 of about 260,978 (210)

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases [PDF]

open access: yesFrontiers in Immunology, 2021
Interferon λ (IFN-λ) is critical for host viral defense at mucosal surfaces and stimulates immunomodulatory signals, acting on epithelial cells and few other cell types due to restricted IFN-λ receptor expression. Epithelial cells of the intestine play a
David A Constant, Timothy J Nice
exaly   +7 more sources

Macrophage Coordination of the Interferon Lambda Immune Response [PDF]

open access: yesFrontiers in Immunology, 2019
Lambda interferons (IFN-λs) are a major component of the innate immune defense to viruses, bacteria, and fungi. In human liver, IFN-λ not only drives antiviral responses, but also promotes inflammation and fibrosis in viral and non-viral diseases.
Vincent Lam, Scott Read, David Booth
exaly   +6 more sources

Interferon Lambda Signaling in Macrophages Is Necessary for the Antiviral Response to Influenza [PDF]

open access: yesFrontiers in Immunology, 2021
Interferon lambda (IFNλ) signaling is a promising therapeutic target against viral infection in murine models, yet little is known about its molecular regulation and its cognate receptor, interferon lambda receptor 1 (IFNLR1) in human lung.
James Londino   +2 more
exaly   +4 more sources

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling [PDF]

open access: yesViruses, 2023
Interferon lambdas (IFNLs) are innate immune cytokines that induce antiviral cellular responses by signaling through a heterodimer composed of IL10RB and the interferon lambda receptor 1 (IFNLR1). Multiple IFNLR1 transcriptional variants are expressed in
Grayson Evans   +2 more
exaly   +4 more sources

Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium [PDF]

open access: yesFrontiers in Immunology
Type III interferon (IFN-λ), a new member of the IFN family, was initially considered to possess antiviral functions similar to those of type I interferon, both of which are induced via the JAK/STAT pathway.
Yong-Hong Liao   +2 more
exaly   +4 more sources

Interferon Lambda: The Next Frontier in Antiviral Therapy? [PDF]

open access: yesPharmaceuticals
Type III interferons (IFN-λ) are the most recently identified members of the interferon family, distantly related to type I interferons and members of the interleukin-10 (IL-10).
Sofia Chronopoulou, Ilias Tsochantaridis
doaj   +2 more sources

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir

open access: yesMicroorganisms, 2021
Influenza viruses are a leading cause of morbidity and mortality worldwide. These air-borne pathogens are able to cross the species barrier, leading to regular seasonal epidemics and sporadic pandemics.
Caroline Tapparel Vu   +2 more
exaly   +3 more sources

Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis [PDF]

open access: yesBiomedicines
IFN-λ is a type III interferon (IFN) with pleiotropic functions in modulating immune responses. To address its function in autoimmune neuroinflammation, we evaluated the development and progression of experimental autoimmune encephalitis (EAE) in IFNLR1 ...
Mohammad Asif Sherwani   +4 more
doaj   +2 more sources

Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice [PDF]

open access: yesVirus Research
Recent studies indicate that treatment of chronic hepatitis D virus (HDV) with either pegylated interferon (IFN)λ or pegylated IFNα monotherapy leads to a dramatic decline in HDV RNA. Herein, we investigated the innate antiviral efficacy of IFNλ and IFNα
Sarah Duehren   +12 more
doaj   +2 more sources

Conserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins

open access: yesFrontiers in Immunology, 2021
Interferon lambdas (IFNλ) (also known as type III IFNs) are critical cytokines that combat infection predominantly at barrier tissues, such as the lung, liver, and gastrointestinal tract. Humans have four IFNλs (1–4), where IFNλ1–3 show ~80%–95% homology,
Steeve Boulant   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy